Table 1.

Demographic and clinical data.

	Patients (n = 17)	Controls (n = 34)
Female/male	11/6	19/15
Age (years)	45.3 ± 16.7	45.9 ± 14.1
Duration of illness (years)	18.4 ± 12.5	n/a
Antipsychotic drugs (CPZ‐eq mg)	748 ± 625.4	n/a

Note: Data are shown as the mean ± standard deviation. The daily dose of antipsychotic drugs was quantified in chlorpromazine equivalents (CPZ‐eq).